TLX

Telix Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 0/10
  • Momentum↓ 1/10
Telix Pharmaceuticals sales and earnings growth
TLX Growth
Low
  • Revenue Y/Y↑ 141.40%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -639.61%
Telix Pharmaceuticals gross and profit margin trends
TLX Profitability
Good
  • Gross margin ↑ 53.10%
  • EPS margin↓ -0.90%
  • ROIC↓ 6.70%
Telix Pharmaceuticals net debt vs free cash flow
TLX Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↑ 7.6
  • Interest coverage↓ 0.9

Telix Pharmaceuticals stock volatility is in-line with the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗